{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:40:05Z","timestamp":1783381205252,"version":"3.54.6"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ophtha.2008.04.033","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:00:56Z","timestamp":1221739256000},"page":"1957-1964.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease"],"prefix":"10.1016","volume":"115","author":[{"given":"Wai T.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna R.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2008.04.033_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ophtha.2008.04.033_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archopht.125.2.239","article-title":"Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis","volume":"125","author":"Wong","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.033_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2007.03.009","article-title":"Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.033_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","article-title":"von Hippel-Lindau disease","volume":"46","author":"Singh","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.033_bib5","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0161-6420(00)00422-X","article-title":"Juxtapapillary capillary hemangiomas: clinical features and visual acuity outcomes","volume":"107","author":"McCabe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.033_bib6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","article-title":"Treatment of retinal capillary hemangioma","volume":"109","author":"Singh","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.033_bib7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0161-6420(02)01059-X","article-title":"Benefits and complications of photodynamic therapy of papillary capillary hemangiomas","volume":"109","author":"Schmidt-Erfurth","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.033_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ophtha.2008.04.033_bib9","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.94.16.8761","article-title":"Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal","volume":"94","author":"Benjamin","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2008.04.033_bib10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor","volume":"98","author":"Haase","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2008.04.033_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1200\/JCO.2005.01.186","article-title":"Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma","volume":"23","author":"Rini","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2008.04.033_bib12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","article-title":"Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416","volume":"109","author":"Aiello","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.033_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.04.033_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.eye.6702896","article-title":"Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy [letter]","volume":"21","author":"Ziemssen","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2008.04.033_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0420.2006.00825.x","article-title":"Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma","volume":"85","author":"von Buelow","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2008.04.033_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/IAE.0b013e318030a290","article-title":"Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina","volume":"27","author":"Dahr","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2008.04.033_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1167\/iovs.04-0601","article-title":"Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration","volume":"46","author":"Gaudreault","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.04.033_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.exer.2007.05.008","article-title":"Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo","volume":"85","author":"Lowe","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2008.04.033_bib19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.04.033_bib20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2006.04.033","article-title":"A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema","volume":"113","author":"Chun","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.04.033_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","article-title":"Lindau's disease: review of the literature and study of a large kindred","volume":"36","author":"Melmon","year":"1964","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2008.04.033_bib22","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI114322","article-title":"Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis","volume":"84","author":"Connolly","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ophtha.2008.04.033_bib23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.291.8.943","article-title":"Antiangiogenic therapy for von Hippel-Lindau disease [letter]","volume":"291","author":"Madhusudan","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2008.04.033_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08820530500350787","article-title":"Anti-angiogenic therapy: prospects for treatment of ocular tumors","volume":"21","author":"Rosenblatt","year":"2006","journal-title":"Semin Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008004211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008004211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:57:08Z","timestamp":1758981428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642008004211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0161642008004211"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.04.033","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}